Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:48 UTC |
---|
HMDB ID | HMDB0014982 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Nalbuphine |
---|
Description | Nalbuphine is only found in individuals that have used or taken this drug. It is a narcotic used as a pain medication. It appears to be an agonist at kappa opioid receptors and an antagonist or partial agonist at mu opioid receptors. [PubChem]The exact mechanism of action is unknown, but is believed to interact with an opiate receptor site in the CNS (probably in or associated with the limbic system). The opiate antagonistic effect may result from competitive inhibition at the opiate receptor, but may also be a result of other mechanisms. Nalbuphine is thought primarily to be a kappa agonist. It is also a partial mu antagonist analgesic, with some binding to the delta receptor and minimal agonist activity at the sigma receptor. |
---|
Structure | O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5 InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19-,20-,21+/m0/s1 |
---|
Synonyms | Value | Source |
---|
N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol | ChEBI | Nalbufina | ChEBI | Nalbuphinum | ChEBI | Intapan | Kegg | N-Cyclobutylmethyl-4,5a-epoxy-3,6a,14-morphinantriol | Generator | N-Cyclobutylmethyl-4,5α-epoxy-3,6α,14-morphinantriol | Generator | Nubain | HMDB | Nalbuphine serb brand | HMDB | Hydrochloride, nalbuphine | HMDB | Serb, nalbuphine | HMDB | Nalbuphine hydrochloride | HMDB | Nalbuphine serb | HMDB | SERB brand OF nalbuphine | HMDB |
|
---|
Chemical Formula | C21H27NO4 |
---|
Average Molecular Weight | 357.4434 |
---|
Monoisotopic Molecular Weight | 357.194008357 |
---|
IUPAC Name | (1S,5R,13R,14S,17S)-4-(cyclobutylmethyl)-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7,9,11(18)-triene-10,14,17-triol |
---|
Traditional Name | nalbuphine |
---|
CAS Registry Number | 20594-83-6 |
---|
SMILES | O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5 |
---|
InChI Identifier | InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19-,20-,21+/m0/s1 |
---|
InChI Key | NETZHAKZCGBWSS-CEDHKZHLSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenanthrenes and derivatives. These are polycyclic compounds containing a phenanthrene moiety, which is a tricyclic aromatic compound with three non-linearly fused benzene. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Phenanthrenes and derivatives |
---|
Sub Class | Not Available |
---|
Direct Parent | Phenanthrenes and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Phenanthrene
- Tetralin
- Coumaran
- 1-hydroxy-2-unsubstituted benzenoid
- Alkyl aryl ether
- Aralkylamine
- Piperidine
- Cyclic alcohol
- Tertiary alcohol
- 1,2-aminoalcohol
- Secondary alcohol
- Tertiary aliphatic amine
- Tertiary amine
- Ether
- Oxacycle
- Polyol
- Azacycle
- Organoheterocyclic compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Alcohol
- Organic oxygen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 230 °C (hydrochloride salt) | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 2.09 g/L | Not Available | LogP | 1.4 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Nalbuphine,1TMS,isomer #1 | C[Si](C)(C)O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5 | 2889.1 | Semi standard non polar | 33892256 | Nalbuphine,1TMS,isomer #2 | C[Si](C)(C)O[C@@]12CC[C@H](O)[C@@H]3OC4=C(O)C=CC5=C4[C@@]31CCN(CC1CCC1)[C@@H]2C5 | 2877.2 | Semi standard non polar | 33892256 | Nalbuphine,1TMS,isomer #3 | C[Si](C)(C)OC1=CC=C2C[C@H]3N(CC4CCC4)CC[C@]45C2=C1O[C@H]4[C@@H](O)CC[C@@]35O | 2931.9 | Semi standard non polar | 33892256 | Nalbuphine,2TMS,isomer #1 | C[Si](C)(C)O[C@H]1CC[C@@]2(O[Si](C)(C)C)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5 | 2820.9 | Semi standard non polar | 33892256 | Nalbuphine,2TMS,isomer #2 | C[Si](C)(C)OC1=CC=C2C[C@H]3N(CC4CCC4)CC[C@]45C2=C1O[C@H]4[C@@H](O[Si](C)(C)C)CC[C@@]35O | 2890.3 | Semi standard non polar | 33892256 | Nalbuphine,2TMS,isomer #3 | C[Si](C)(C)OC1=CC=C2C[C@H]3N(CC4CCC4)CC[C@]45C2=C1O[C@H]4[C@@H](O)CC[C@@]35O[Si](C)(C)C | 2868.5 | Semi standard non polar | 33892256 | Nalbuphine,3TMS,isomer #1 | C[Si](C)(C)OC1=CC=C2C[C@H]3N(CC4CCC4)CC[C@]45C2=C1O[C@H]4[C@@H](O[Si](C)(C)C)CC[C@@]35O[Si](C)(C)C | 2871.6 | Semi standard non polar | 33892256 | Nalbuphine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5 | 3120.5 | Semi standard non polar | 33892256 | Nalbuphine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)O[C@@]12CC[C@H](O)[C@@H]3OC4=C(O)C=CC5=C4[C@@]31CCN(CC1CCC1)[C@@H]2C5 | 3114.8 | Semi standard non polar | 33892256 | Nalbuphine,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=CC=C2C[C@H]3N(CC4CCC4)CC[C@]45C2=C1O[C@H]4[C@@H](O)CC[C@@]35O | 3166.5 | Semi standard non polar | 33892256 | Nalbuphine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@H]1CC[C@@]2(O[Si](C)(C)C(C)(C)C)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5 | 3294.6 | Semi standard non polar | 33892256 | Nalbuphine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC=C2C[C@H]3N(CC4CCC4)CC[C@]45C2=C1O[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@@]35O | 3363.1 | Semi standard non polar | 33892256 | Nalbuphine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=CC=C2C[C@H]3N(CC4CCC4)CC[C@]45C2=C1O[C@H]4[C@@H](O)CC[C@@]35O[Si](C)(C)C(C)(C)C | 3354.9 | Semi standard non polar | 33892256 | Nalbuphine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C2C[C@H]3N(CC4CCC4)CC[C@]45C2=C1O[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@@]35O[Si](C)(C)C(C)(C)C | 3564.5 | Semi standard non polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Nalbuphine GC-MS (Non-derivatized) - 70eV, Positive | splash10-056u-9024000000-f340950b62bc62155aad | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nalbuphine GC-MS (3 TMS) - 70eV, Positive | splash10-0a6r-7200190000-d65993f303318329695e | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nalbuphine GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nalbuphine GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nalbuphine GC-MS (TBDMS_3_1) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nalbuphine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nalbuphine GC-MS ("Nalbuphine,2TMS,#3" TMS) - 70eV, Positive | Not Available | 2021-10-14 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Nalbuphine 35V, Positive-QTOF | splash10-052f-0019000000-d9843432af7f0b68c123 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nalbuphine 10V, Positive-QTOF | splash10-052f-2009000000-ebce756d2f09cd1910ab | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nalbuphine 20V, Positive-QTOF | splash10-014i-9007000000-bbd85f5711c7e46af99d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nalbuphine 40V, Positive-QTOF | splash10-014i-9000000000-915ad990f371c4dabcfc | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nalbuphine 10V, Negative-QTOF | splash10-0a4i-0019000000-540f9874c968fbe7262c | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nalbuphine 20V, Negative-QTOF | splash10-052r-1039000000-aa9a27b2348aafb5a2e8 | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nalbuphine 40V, Negative-QTOF | splash10-05g3-3090000000-fe24dd502f436a5787fa | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nalbuphine 10V, Positive-QTOF | splash10-0a4i-0009000000-9957b000ea8c41ed8257 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nalbuphine 20V, Positive-QTOF | splash10-0a4i-0009000000-f48c8684121f5d183a1c | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nalbuphine 40V, Positive-QTOF | splash10-0zfr-0019000000-e87bebcd47bdb1e8e0a4 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nalbuphine 10V, Negative-QTOF | splash10-0a4i-0009000000-66d5ef9d584e1b0274e8 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nalbuphine 20V, Negative-QTOF | splash10-0a4i-0009000000-66d5ef9d584e1b0274e8 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nalbuphine 40V, Negative-QTOF | splash10-0a4i-0019000000-3615de25291d9c20f0e3 | 2021-10-11 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00844 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00844 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Predicted Concentrations |
---|
| |
Blood | 0.000 uM | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities | Blood | 0.000 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities |
|
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00844 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 4470813 |
---|
KEGG Compound ID | C07251 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Nalbuphine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 5311304 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 7454 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, Levine JD: The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain. Pain. 1999 Nov;83(2):339-45. [PubMed:10534607 ]
|
---|